Table 1

Baseline demographic and clinical data of rheumatoid arthritis patients in different 12-month remission statuses
Whole cohort (n= 273) DAS28 remission (n= 102) Only DAS28 remission (n= 75) DAS28 + Boolean remission (n= 27) Not in any remission (n= 171)
Age (years) 59.89 (7 to 85) 57.12 (7 to 85) 59.17 (26 to 85) 51.43 (7 to 75) 61.53 (30 to 86)
Disease duration (years) 13.43 (1 to 52) 11.1 (1 to 40) 12,23 (1 to 40) 7.91 (1 to 21) 14.68 (1 to 52)
Female (%) 74.7 68.6 66.7 74.1 78.4
RF positivity (%) 70.2 69.7 71.2 65.4 70.5
Anti-CCP positivity (%) 75.2 69.4 65.7 78.6 79.7
DAS28(4v)-CRP 5.33 ± 1.07 5.15 ± 1.1 5.18 ± 1.16 5.08 ± 0.9 5.44 ± 1.05
TJC28 10.24 ± 6.86 8.71 ± 6.83 9.19 ± 7.34 7.37 ± 5.05 11.15 ± 6.73
SJC28 9.86 ± 6.20 9.6 ± 6.25 9.73 ± 6.57 9.22 ± 5.36 10.02 ± 6.19
CRP (mg/dl) 2.76 ± 2.93 3.16 ± 3.14 3.23 ± 3.12 2.93 ± 3.26 2.53 ± 2.78
PGH 5.92 ± 2.28 5.6 ± 2.29 5.57 ± 2.33 5.68 ± 2.22 6.12 ± 2.26

Data presented as mean (range), mean ± standard deviation or percentage. DAS28, disease activity score based on 28-joint count; RF, rheumatoid factor; anti-CCP, anti-cyclic-citrullinated peptide antibody; DAS28(4v)-CRP, disease activity score based on 28-joint count, C-reactive protein and patient global health; TJC28, tender joint count out of 28 joints; SJC28, swollen joint count out of 28 joints; CRP, C-reactive protein; PGH, patient global health.

Balogh et al.

Balogh et al. Arthritis Research & Therapy 2013 15:R221   doi:10.1186/ar4421

Open Data